This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (53)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Prognosis/ Outcomes  • Stroke  • Metabolic Diseases  • Alert me on articles by topic

S. Goya Wannamethee, PhD; A. Gerald Shaper, FRCP; Lucy Lennon, MSc; Richard W. Morris, PhD

Arch Intern Med. 2005;165:2644-2650.

Background  We sought to compare metabolic syndrome (MetS) with the Framingham Risk Score (FRS) as predictors of coronary heart disease (CHD), stroke, and type 2 diabetes mellitus (DM2) in middle-aged men.

Methods  A prospective study of 5128 men aged 40 to 59 years with no history of cardiovascular disease (CVD) (CHD or stroke) or DM2 drawn from general practices in 24 British towns and observed for 20 years. Metabolic syndrome was defined as the presence of 3 or more metabolic abnormalities based on modified National Cholesterol Education Program criteria.

Results  Men with MetS at baseline (26%) showed significantly higher relative risk (RR) than men without MetS of developing CHD (RR, 1.64; 95% confidence interval [CI], 1.41-1.90), stroke (RR, 1.61 95% CI, 1.26-2.06), and DM2 (RR, 3.57; 95% CI, 2.83-4.50). The probability of developing CVD or DM2 over 20 years increased from 11.9% in those with no abnormalities to 31.2% in those with 3 abnormalities to 40.8% in those with 4 or 5 abnormalities. The FRS was a better predictor of CHD and stroke than MetS but was less predictive of DM2. Areas under the receiver-operating characteristic curves for FRS vs the number of metabolic abnormalities were 0.68 vs 0.59 for CHD, 0.60 vs 0.70 for DM2, and 0.66 vs 0.55 for stroke (P<.001 for all).

Conclusions  Presence of MetS is a significant predictor of CVD and DM2 but is a stronger predictor of DM2 than of CHD. Although MetS does not predict CHD as well as the FRS, it serves well as a simple clinical tool for identifying high-risk subjects predisposed to CVD or DM2.

Author Affiliations: Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, England.

RELATED ARTICLE

Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease
Priya Kohli and Philip Greenland
JAMA. 2006;295(7):819-821.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland
Wang et al.
Stroke 2008;39:1078-1083.
ABSTRACT | FULL TEXT  

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D'Agostino et al.
Circulation 2008;117:743-753.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2008;117:e25-e146.
FULL TEXT  

Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia
Fenton and Chavez
Focus 2008;6:246-253.
ABSTRACT | FULL TEXT  

Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence
Preiss and Sattar
Heart 2007;93:1493-1496.
ABSTRACT | FULL TEXT  

The 2005 Dietary Guidelines for Americans and risk of the metabolic syndrome
Fogli-Cawley et al.
Am. J. Clin. Nutr. 2007;86:1193-1201.
ABSTRACT | FULL TEXT  

Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study
Elwood et al.
J. Epidemiol. Community Health 2007;61:695-698.
ABSTRACT | FULL TEXT  

Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans?
Blaum et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:766-773.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Arenillas et al.
Stroke 2007;38:2196-2203.
FULL TEXT  

Relationship Between Metabolic Risk Factor Clustering and Cardiovascular Mortality Stratified by High Blood Glucose and Obesity: NIPPON DATA90, 1990-2000
Kadota et al.
Diabetes Care 2007;30:1533-1538.
ABSTRACT | FULL TEXT  

Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Kahn
Circulation 2007;115:1806-1811.
FULL TEXT  

The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns
Wang et al.
Eur Heart J 2007;28:857-864.
ABSTRACT | FULL TEXT  

Development of Age-Specific Adolescent Metabolic Syndrome Criteria That Are Linked to the Adult Treatment Panel III and International Diabetes Federation Criteria
Jolliffe and Janssen
J Am Coll Cardiol 2007;49:891-898.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT  

The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes
Lorenzo et al.
Diabetes Care 2007;30:8-13.
ABSTRACT | FULL TEXT  

Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis
Mancia et al.
Hypertension 2007;49:40-47.
ABSTRACT | FULL TEXT  

Design and validation of a population-based definition of the metabolic syndrome.
Aguilar-Salinas et al.
Diabetes Care 2006;29:2420-2426.
ABSTRACT | FULL TEXT  

Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia
Fenton and Chavez
Am. J. Psychiatry 2006;163:1697-1704.
FULL TEXT  

Clinical Use of the Metabolic Syndrome: Why the Confusion?
Blaha and Elasy
Clin. Diabetes 2006;24:125-131.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome (Emperor) Wears No Clothes
Kahn
Diabetes Care 2006;29:1693-1696.
FULL TEXT  

Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease
Kohli and Greenland
JAMA 2006;295:819-821.
FULL TEXT